Monolith Management’s Hims & Hers Health HIMS Stock Holding History

Monolith Management’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-191,500	Closed	-$4.63M	–	21
2024 Q4	$4.63M	Buy	+191,500	New	+$4.74M	2.35%	16

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Monolith Management's HIMS Position: Q1 2025 in Review

Monolith Management sold out of Hims & Hers Health (HIMS) in Q1 2025, closing a stake of 191,500 shares — an estimated $4.63M sold.

Monolith Management first reported a position in HIMS in Q4 2024 and held it in 1 quarter. The position peaked at $4.63M in Q4 2024. 429 funds tracked by Wall St. Rank hold HIMS as of Q1 2025.

Monolith Management reported no remaining Hims & Hers Health position as of Q1 2025 after selling out during the quarter.
Monolith Management sold 191,500 Hims & Hers Health shares in Q1 2025, an estimated $4.63M.
Monolith Management first reported a position in Hims & Hers Health in Q4 2024 and held it in 1 quarter.
Monolith Management's Hims & Hers Health position peaked at $4.63M in Q4 2024.
429 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2025.

Based on Monolith Management's 13F filing for Q1 2025, filed 14 May 2025.